The atopic march: Critical evidence and clinical relevance
- PMID: 29413336
- PMCID: PMC5806141
- DOI: 10.1016/j.anai.2017.10.037
The atopic march: Critical evidence and clinical relevance
Erratum in
-
Erratum.Ann Allergy Asthma Immunol. 2018 Apr;120(4):451. doi: 10.1016/j.anai.2018.02.033. Epub 2018 Mar 9. Ann Allergy Asthma Immunol. 2018. PMID: 29526604 No abstract available.
Conflict of interest statement
Disclosure: The authors have no financial relationships or other conflicts of interest relevant to this article to disclose
Figures
References
-
- Cohen S, Dworetzky M, Frick OL. Coca and Cooke on the classification of hypersensitiveness. J Allergy Clin Immunol. 2003;111:205–210. - PubMed
-
- Bloom B, Jones LI, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2012. Vital Health Stat. 2013;10(258):1–81. - PubMed
-
- Marenholz I, Esparza-Gordillo J, Lee YA. The genetics of the skin barrier in eczema and other allergic disorders. Curr Opin Allergy Clin Immunol. 2015;15:426–434. - PubMed
-
- Rogers AJ, Celedon JC, Lasky-Su JA, Weiss ST, Raby BA. Filaggrin mutations confer susceptibility to atopic dermatitis but not to asthma. J Allergy Clin Immunol. 2007;120:1332–1337. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
